Objective:To observe the curative effect of Shensong Yangxin Capsule in the treatment of coronary heart disease and arrhythmia.Methods:Eighty-eight cases were divided into the control group(43 cases)and the observation group(45 cases)according to different treatment methods.Both groups were treated with metoprolol succinate sustained-release tablets and the observation group was treated with Shensong Yangxin Capsule in addition.Results:The total effective rate of the observation group was higher than that of the control group(P<0.05).After treatment,the levels of serum PCT,CRP and IL-6 in the two groups were lower than those before treatment(P<0.05),and those in the observation group were lower than the control group(P<0.05).After treatment,the levels of plasma specific viscosity,fibrinogen and hematocrit in the two groups were lower than those before treatment(P<0.05),and those in the observation group were lower than the control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Shensong Yangxin Capsule could improve the curative effect in the treatment of coronary heart disease and arrhythmia,with safety.
Coronary heart diseaseArrhythmiaShensong Yangxin CapsuleControl treatment and observation
万方数据
维普
